These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 32654163)

  • 41. Skin Testing and Drug Provocation Tests Should Be Performed in the Context of Drug Reaction with Eosinophilia and Systemic Symptoms: A Cohort Study.
    Toulemonde É; Lannoy D; Gautier S; Stéfanski M; Miaux C; Azib-Meftah S; Staumont-Sallé D; Dezoteux F
    Dermatitis; 2024; 35(4):415-417. PubMed ID: 37972110
    [No Abstract]   [Full Text] [Related]  

  • 42. Drug Reaction With Eosinophilia and Systemic Symptoms With Pustulosis.
    Hansen E; Kirven RM; Gallardo M; Chung CG; Fisher K; Kaffenberger BH; Korman AM
    JAMA Dermatol; 2024 Jul; 160(7):777-779. PubMed ID: 38748440
    [TBL] [Abstract][Full Text] [Related]  

  • 43. DRESS syndrome presenting like septic shock.
    Parkins G; White B
    QJM; 2013 Jul; 106(7):671-3. PubMed ID: 23474419
    [No Abstract]   [Full Text] [Related]  

  • 44. Drug-induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms Caused by Lenalidomide: Case Report and Review of the Literature.
    Osada SI; Sato T
    Acta Derm Venereol; 2021 May; 101(5):adv00468. PubMed ID: 34027556
    [No Abstract]   [Full Text] [Related]  

  • 45. Red herring in returned traveler: drug reaction with eosinophilia and systemic symptom (DRESS) syndrome mimicking sepsis.
    Lim HY; Huang GK; Torresi J; Johnson D
    J Travel Med; 2014; 21(6):425-8. PubMed ID: 25345985
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Understanding the patient experience of drug reaction with eosinophilia and systemic symptoms: A qualitative study.
    Samarakoon U; Wolfson AR; Zhou L; Bassir F; Phillips E; Kroshinsky D; Cucka B; Biglione B; Phadke NA; Jaggers J; Byrne EC; Judd AD; Blumenthal KG
    J Am Acad Dermatol; 2024 Aug; 91(2):370-373. PubMed ID: 38677336
    [No Abstract]   [Full Text] [Related]  

  • 47. Drug Reaction with Eosinophilia and Systemic Symptoms: A Complex Interplay between Drug, T Cells, and Herpesviridae.
    Ganeshanandan L; Lucas M
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498771
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Letter from the Editor: Drug reaction with eosinophilia and systemic symptoms syndrome.
    Elston DM
    J Am Acad Dermatol; 2024 Jun; 90(6):1153-1154. PubMed ID: 37276932
    [No Abstract]   [Full Text] [Related]  

  • 49. Potassium-paraaminobenzoic acid (Potaba®)-associated DRESS syndrome.
    Viehweg A; Stein A; Bauer A; Spornraft-Ragaller P
    Dermatitis; 2013; 24(5):257-8. PubMed ID: 24045650
    [No Abstract]   [Full Text] [Related]  

  • 50. DRESS syndrome: a detailed insight.
    Behera SK; Das S; Xavier AS; Selvarajan S
    Hosp Pract (1995); 2018 Aug; 46(3):152-162. PubMed ID: 29519170
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Drug rash with eosinophilia and systemic symptoms syndrome without eosinophilia managed with intravenous immunoglobulin.
    Kerkemeyer KLS; Lee S; Lai FYX; Mar A
    Intern Med J; 2020 Sep; 50(9):1156-1157. PubMed ID: 32827350
    [No Abstract]   [Full Text] [Related]  

  • 52. Purpura as an indicator of severity in drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms: evidence from a 49-case series.
    Takei S; Hama N; Mizukawa Y; Takahashi H; Miyagawa F; Asada H; Abe R
    J Eur Acad Dermatol Venereol; 2022 Apr; 36(4):e310-e313. PubMed ID: 34839562
    [No Abstract]   [Full Text] [Related]  

  • 53. Drug reaction with eosinophilia and systemic symptoms syndrome induced by apixaban.
    Menteşoğlu D; Doğan Günaydın S; Ersoy-Evans S
    Dermatol Ther; 2020 Jul; 33(4):e13719. PubMed ID: 32472629
    [No Abstract]   [Full Text] [Related]  

  • 54. Impact of systemic to topical steroids switch on the outcome of drug reaction with eosinophilia and systemic symptoms (DRESS): A monocenter retrospective study of 20 cases.
    Brin C; Bernigaud C; Hua C; Duong TA; Gaudin O; Colin A; de Prost N; Wolkenstein P; Chosidow O; Ingen-Housz-Oro S
    Ann Dermatol Venereol; 2021 Sep; 148(3):168-171. PubMed ID: 33858692
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antipsychotic-Induced Drug Rash With Eosinophilia and Systemic Symptoms Syndrome: A Case Report.
    Gica Ş; Elmaci ZC; Balaban ÖD; Karamustafalioglu N
    Am J Ther; 2021 Mar-Apr 01; 28(2):e253-e254. PubMed ID: 31513024
    [No Abstract]   [Full Text] [Related]  

  • 56. Drug reaction with eosinophilia and systemic symptoms within 1 week of exposure to the drug.
    Sasidharanpillai S; Ajithkumar K; Khader A; Reena Mariyath OK
    J Am Acad Dermatol; 2020 Jul; 83(1):e17-e18. PubMed ID: 32179083
    [No Abstract]   [Full Text] [Related]  

  • 57. Drug Reaction With Eosinophilia and Systemic Symptoms.
    Krantz MS; Phillips EJ
    JAMA Dermatol; 2023 Mar; 159(3):348. PubMed ID: 36630118
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic syndrome followed by transient palmoplantar keratoderma-like eruption.
    Nomura T; Nakajima S; Kashiwa A; Matsuyama K; Hirata M; Ueshima C; Kataoka TR; Kabashima K; Matsui M
    J Dermatol; 2021 May; 48(5):e207-e209. PubMed ID: 33630361
    [No Abstract]   [Full Text] [Related]  

  • 59. Drug Reaction with Eosinophilia and Systemic Symptoms.
    Hung WK; Chung WH
    N Engl J Med; 2022 Jul; 387(2):167. PubMed ID: 35830643
    [No Abstract]   [Full Text] [Related]  

  • 60. Drug reaction with eosinophilia and systemic symptoms after ocrelizumab therapy.
    Nylund M; Vuorinen T; Airas L
    Mult Scler Relat Disord; 2020 Jul; 42():102058. PubMed ID: 32208345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.